scholarly article | Q13442814 |
P2093 | author name string | Floyd E Romesberg | |
Ryan T Cirz | |||
P2860 | cites work | Inhibition of mutation and combating the evolution of antibiotic resistance | Q21146100 |
SOS-induced DNA polymerases enhance long-term survival and evolutionary fitness | Q24530758 | ||
Mutations of Bacteria from Virus Sensitivity to Virus Resistance | Q24533278 | ||
Adaptive mutation: implications for evolution | Q24623723 | ||
The complete genome sequence of Escherichia coli K-12 | Q27860542 | ||
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update | Q28143206 | ||
Biochemistry and genetics of eukaryotic mismatch repair | Q28282377 | ||
The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants | Q28492576 | ||
Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes | Q29615258 | ||
The distribution of the numbers of mutants in bacterial populations | Q29620123 | ||
Isolation and characterization of two Saccharomyces cerevisiae genes encoding homologs of the bacterial HexA and MutS mismatch repair proteins | Q33960283 | ||
Mutants of Escherichia coli with increased fidelity of DNA replication | Q33961314 | ||
Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community | Q33971262 | ||
Mutator natural Escherichia coli isolates have an unusual virulence phenotype. | Q34005449 | ||
Mutator bacteria as a risk factor in treatment of infectious diseases | Q34113782 | ||
Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. | Q34231146 | ||
Evolving responsively: adaptive mutation | Q34297067 | ||
Evolution of high mutation rates in experimental populations of E. coli | Q34429727 | ||
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
Specialized DNA polymerases, cellular survival, and the genesis of mutations | Q34662609 | ||
Mismatch repair protein MutL becomes limiting during stationary-phase mutation | Q35190848 | ||
Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction | Q35343881 | ||
UmuD'(2)C is an error-prone DNA polymerase, Escherichia coli pol V. | Q35588920 | ||
Proliferation of mutators in A cell population | Q35618973 | ||
Negative regulation of mutS and mutH repair gene expression by the Hfq and RpoS global regulators of Escherichia coli K-12. | Q35633546 | ||
SOS mutator activity: unequal mutagenesis on leading and lagging strands. | Q35822001 | ||
Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. | Q36048167 | ||
Mechanisms and biological effects of mismatch repair | Q37041860 | ||
Contribution of the mismatch DNA repair system to the generation of stationary-phase-induced mutants of Bacillus subtilis | Q37513635 | ||
Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections | Q37598703 | ||
Adaptive mutations produce resistance to ciprofloxacin. | Q39784978 | ||
Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies | Q40477935 | ||
Mismatch repair, genetic stability, and cancer | Q40556409 | ||
SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. | Q40943537 | ||
Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics | Q41311524 | ||
SOS response induction by beta-lactams and bacterial defense against antibiotic lethality | Q45016731 | ||
Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum | Q45044337 | ||
High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
Role of mutator alleles in adaptive evolution. | Q54564129 | ||
Costs and Benefits of High Mutation Rates: Adaptive Evolution of Bacteria in the Mouse Gut | Q56944626 | ||
Highly Variable Mutation Rates in Commensal and Pathogenic Escherichia coli | Q56944671 | ||
PCR-mediated gene replacement in Escherichia coli | Q73682242 | ||
Hypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance | Q79162727 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 220-225 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria | |
P478 | volume | 50 |
Q27677020 | A strategically located serine residue is critical for the mutator activity of DNA polymerase IV from Escherichia coli |
Q24647468 | An SOS-regulated type 2 toxin-antitoxin system |
Q35629407 | An editing-defective aminoacyl-tRNA synthetase is mutagenic in aging bacteria via the SOS response |
Q36499774 | Bacterial stationary-state mutagenesis and Mammalian tumorigenesis as stress-induced cellular adaptations and the role of epigenetics |
Q34953383 | Breaking the rules: bacteria that use several DNA polymerase IIIs |
Q36914997 | Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation. |
Q35634868 | Complete and SOS-mediated response of Staphylococcus aureus to the antibiotic ciprofloxacin |
Q36961674 | Controlling mutation: intervening in evolution as a therapeutic strategy |
Q29346807 | Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin |
Q36901628 | Development of tRNA synthetases and connection to genetic code and disease |
Q54372713 | Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials. |
Q42577782 | Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli |
Q41773256 | Effects of subinhibitory concentrations of antibiotics on SOS and DNA repair gene expression in Staphylococcus aureus |
Q38198853 | Genomic insights into tuberculosis |
Q42210567 | Induction of mycobacterial resistance to quinolone class antimicrobials |
Q36624120 | Lex marks the spot: the virulent side of SOS and a closer look at the LexA regulon |
Q42234726 | Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates |
Q36683593 | Multiple Pathways of Genome Plasticity Leading to Development of Antibiotic Resistance. |
Q35869358 | Mutation as a stress response and the regulation of evolvability |
Q42947152 | Novel approach for comparing the abilities of quinolones to restrict the emergence of resistant mutants during quinolone exposure |
Q38309969 | PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa. |
Q92132589 | Prevalence of Antimicrobial Resistance and Hemolytic Phenotypes in Culturable Arctic Bacteria |
Q42264036 | Quinolone Resistance Reversion by Targeting the SOS Response. |
Q37595559 | Quinolones: action and resistance updated |
Q36834425 | Resistance to ocular antibiotics: an overview |
Q37656663 | Ribosomal mutations promote the evolution of antibiotic resistance in a multidrug environment |
Q37072051 | SOS regulation of qnrB expression |
Q26774868 | SOS response and its regulation on the fluoroquinolone resistance |
Q38219786 | SOS, the formidable strategy of bacteria against aggressions. |
Q34056695 | Selection of dinB alleles suppressing survival loss upon dinB overexpression in Escherichia coli |
Q37274991 | Steric gate variants of UmuC confer UV hypersensitivity on Escherichia coli. |
Q37166834 | Systematically Altering Bacterial SOS Activity under Stress Reveals Therapeutic Strategies for Potentiating Antibiotics |
Q28486717 | Targeting of PBP1 by β-lactams determines recA/SOS response activation in heterogeneous MRSA clinical strains |
Q90227092 | The SOS Response Mediates Sustained Colonization of the Mammalian Gut |
Q34285727 | The evolution of stress-induced hypermutation in asexual populations |
Q92154411 | The plasmid-borne quinolone resistance protein QnrB, a novel DnaA-binding protein, increases the bacterial mutation rate by triggering DNA replication stress |
Q34933315 | Vibrio cholerae triggers SOS and mutagenesis in response to a wide range of antibiotics: a route towards multiresistance |
Q39096063 | Will antimicrobial resistance of BRD pathogens impact BRD management in the future? |
Q59813445 | Zinc Blockade of SOS Response Inhibits Horizontal Transfer of Antibiotic Resistance Genes in Enteric Bacteria |
Search more.